Naprosyn® 500 mg
Naprosyn® 500 mg is indicated for the treatment of mild to moderate pain.
– Symptomatic treatment of rheumatoid arthritis, osteoarthritis, acute episodes of gout and ankylosing spondylitis.
– Symptomatic relief of symptoms in primary dysmenorrhoea.
– Symptomatic treatment of acute migraine attacks.
– Primary and secondary menorrhagia associated with an intrauterine device.
Access technical file Naprosyn®Naprosyn® 500 mg 40 tablets
Naprosyn® 500 mg comprimits, 40 comprimits
Ownership: Atnahs Pharma Netherlands B.V.
Comercialized by: Marketed and distributed in Spain by Laboratorios Rubió as a local representative.
Last update: July 2024
The information contained in this area is directed exclusively to healthcare professionals with the capacity to prescribe or dispense medications.
